Compass Pathways
The Field-Based Health Economics & Outcomes Research (HEOR) Science Liaison serves as a scientific bridge between Compass Pathways and external healthcare decision makers, including MCOs, PBMs, and HTA bodies. This role delivers credible scientific exchange on clinical evidence, real-world evidence, pharmacoeconomics, and health outcomes to support formulary and reimbursement decisions across the full product lifecycle. The position is remote within the United States and involves cultivating peer-to-peer relationships with payer thought leaders to demonstrate the value of innovative mental health therapies.
Headquarters
London, England, United Kingdom
Company Size
51-200 employees
Founded
2016
Compass Pathways is a biotechnology company developing psilocybin-based therapies for treatment-resistant depression and other serious mental health conditions. It conducts clinical research and develops treatment models that combine psychedelic compounds with psychological support.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Compass Pathways.
Right around the average for this role
BREAKING: Second Positive Phase 3 for Compass' Psilocybin, Though Modest Magnitude Raises Questions
3 weeks ago
International HEOR & HTA Associate Director
Novartis
International HEOR & HTA Associate Director
Novartis
International HEOR & HTA Associate Director
Novartis
International HEOR & HTA Associate Director
Novartis
Director, International HEOR & HTA, Immunology
Novartis
Director, International HEOR & HTA, Immunology
Novartis